It is essential that community-based nephrologists and primary care physicians, who are increasingly involved in the management of stable renal allograft recipients, are familiar with new-generation immunosuppressive drugs. This comprehensive article by Arjang Djamali and colleagues is a guide to the pharmacokinetics, dosing, drug–drug interactions and adverse effects of the mainstays of modern immunosuppression; calcineurin inhibitors, antimetabolites, mTOR inhibitors and corticosteroids.
- Millie Samaniego
- Bryan N Becker
- Arjang Djamali
